The WHO report says if health trends continue, a time when typical antibiotics don't work on run of the mill kinds of infections is "a very real possibility for the 21st Century. Patients who came in for treatments for colds and flus were given antibiotics even though such infections don't typically respond to medication. QIDP is part of a program that the administration hopes will encourage drug companies to develop new drugs like Dalvance that will fight the epidemic of antibiotic-resistant infections. The number of health care spread MRSA cases is declining, according to the Centers for Disease Control. -- The U.S. Food and Drug Administration has approved a new drug to treat bacterial skin infections like Methicillin-resistant Staphylococcus aureus, also known as MRSA .